Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
<p>Abstract</p> <p>Background</p> <p>The association of gadolinium-based contrast agents (GBCAs) with nephrogenic systemic fibrosis (NSF) has led to a heightened awareness towards patients’ renal function. Whereas detailed guidelines exist for the use of GBCAs in adult...
Main Authors: | Meng Howard, Grosse-Wortmann Lars |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-08-01
|
Series: | Journal of Cardiovascular Magnetic Resonance |
Online Access: | http://www.jcmr-online.com/content/14/1/56 |
Similar Items
-
The Research foundations : how do we know what we know? /
by: 582742 Woodwell, Douglas author
Published: (2014) -
School leadership development: what we know and how we know it
by: Ruth Jensen
Published: (2016-11-01) -
Moral Hazard in Health Insurance: What We Know and How We Know It
by: Einav, Liran, et al.
Published: (2021) -
The origin of life: what we know, what we can know and what we will never know
by: Addy Pross, et al.
Published: (2013-01-01) -
Analgosedation in neonates: what we know and how we act
by: Allegaert K, et al.
Published: (2013-11-01)